You don’t necessarily have to buy a property and flip it in order to benefit from the booming real estate market. Instead of having to deal with downpayment and mortgages as well as the headaches of ...
Whether your financial target is to get to $500,000 or $5 million, MarketWatch has created a seven-day challenge with expert ideas to help you get there faster in 2026.
A House vote expected this month could offer another chance to extend the subsidies, but success is far from guaranteed.
While studying salmon populations and designing amusement parks, these students are breaking barriers to advanced math that ...
Stacey Canova and Carly Saal, close friends and fellow teachers, have taught first graders at Haledon Public School for more than two decades.
Ben and Erin Napier's daughters have never used — or even held — a smartphone. As a result, they're "probably a little too ...
The market’s biggest risk isn’t a crash — it’s something far quieter. A top-heavy economy is masking deeper structural ...
In 2025, Farmington Area School District constituents approved an operating levy in a November special election after two ...
As each year winds to a close, The Inquirer and Mirror takes a look back on a month-by-month basis at the highs and lows, the joy and heartbreak, that made ...
Whether Wisconsin’s next governor is a Republican or a Democrat, I have compiled a list of New Year’s resolutions for the ...
Officials at Olympia Fields-based Fierce Elite Athletics are firm believers that it’s never too early to start competing on a ...
CRISPR Therapeutics Reports Strong 90% Response Rate and Lupus Remission in Landmark Zugo-Cel Update
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results